Damaskos, C.; Psilopatis, I.; Garmpi, A.; Dimitroulis, D.; Nikolettos, K.; Vrettou, K.; Sarantis, P.; Koustas, E.; Kouraklis, G.; Antoniou, E.A.;
et al. Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer. Cancers 2024, 16, 209.
https://doi.org/10.3390/cancers16010209
AMA Style
Damaskos C, Psilopatis I, Garmpi A, Dimitroulis D, Nikolettos K, Vrettou K, Sarantis P, Koustas E, Kouraklis G, Antoniou EA,
et al. Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer. Cancers. 2024; 16(1):209.
https://doi.org/10.3390/cancers16010209
Chicago/Turabian Style
Damaskos, Christos, Iason Psilopatis, Anna Garmpi, Dimitrios Dimitroulis, Konstantinos Nikolettos, Kleio Vrettou, Panagiotis Sarantis, Evangelos Koustas, Gregory Kouraklis, Efstathios A. Antoniou,
and et al. 2024. "Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer" Cancers 16, no. 1: 209.
https://doi.org/10.3390/cancers16010209
APA Style
Damaskos, C., Psilopatis, I., Garmpi, A., Dimitroulis, D., Nikolettos, K., Vrettou, K., Sarantis, P., Koustas, E., Kouraklis, G., Antoniou, E. A., Karamouzis, M. V., Nikolettos, N., Tsikouras, P., Marinos, G., Kontomanolis, E., Kontzoglou, K., & Garmpis, N.
(2024). Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer. Cancers, 16(1), 209.
https://doi.org/10.3390/cancers16010209